Clinical trial
Stem Cell Support in Patients With Rheumatoid Arthritis
NCT00278551 · Richard Burt, MD, Other · Terminated
Key facts
| NCT number | NCT00278551 |
|---|---|
| Title | Stem Cell Support in Patients With Rheumatoid Arthritis |
| Official title | Immune Ablation and Hematopoietic Stem Cell Support in Patients With Rheumatoid Arthritis and High Risk Factors |
| Lead sponsor | Richard Burt, MD, Other |
| Status | Terminated |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | RHEUMATOID ARTHRITIS |
| Intervention type | Biological |
| Interventions | Immune ablation and hematopoietic stem cell transplant |
| Enrollment | 10 |
| Start date | Jun 1, 1997 |
| Primary completion | Nov 1, 2011 |
| Completion | Nov 1, 2011 |
| First posted | Jan 18, 2006 |
| Last update posted | Apr 8, 2013 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: